Referred to as the "Comfort Cryonics Castle," it was once intended to store human organs and bodies for the "Timeship" ...
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
The latest biotech industry insights, from ELRIG’s newest work group leaders to the launch of a platform for amplifying DNA methylation.
Healthcare Asia Magazine on MSN
Gene and cell therapy boom drives DNA manufacturing market toward $21.82B by 2034
Biotech investments fuel DNA manufacturing in Asia-Pacific. The global DNA manufacturing market is projected to reach $21.82b ...
Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic ...
Built in 1902 to house an eccentric inventor’s rare plant collection, preserving this building in San Francisco has been a ...
Learn more about whether Revvity, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
With aging populations on the rise, the need for better tools to diagnose and monitor Alzheimer's disease (AD), the most common cause of dementia, has never been more urgent. This disease is ...
Dr Singh highlighted India’s unique advantage in genomic research due to its large and genetically diverse population.
Researchers developed a DNA barcoding assay to measure nanoparticle cargo escape in living organisms, enabling a new class of lipid nanoparticles for more efficient gene editing.
By using the biochemistry of Salmon DNA and the delivery power of Spicules, we are giving your cells the "energy" and "bricks" they need to rebuild.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results